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Supplementary Figure 1. TGA curves for gold complexes 1 and 2. 




Supplementary Figure 2. Intermolecular interactions for complex 2.  





     
Supplementary Figure 3. Cyclic voltammetry for complexes 1 and 2. 
(a) reduction (blue) and oxidation (red) cyclic voltammetry scans for gold complex 1. (b) Full 
range cyclic voltammogram for gold complex 2. Recorded using a glassy carbon electrode in 









Supplementary Figure 4. Photoluminescence spectra for complex 1–4. 
Emission spectra for complexes  CMA1 (a), CMA4 (b), 1 (c) and 2 (d) in MeTHF solutions at 







Supplementary Figure 5. Photoluminescence spectra for complex 1–4. 
PL spectra of (a) 3 and (b) 4 at 298K as crystals, in neat film, in frozen MeTHF solution and in 
liquid toluene solution (excitation at 365 nm).  
  
 
Supplementary Figure 6. Electroluminescence spectra.  






Supplementary Figure 7. Current density-voltage-luminance (J-V-L) curves. 
a Current density-voltage. b luminance-voltage characteristics for OLEDs based on complexes 3 
and 4  
 
 
Supplementary Figure 8. External electroluminescence quantum efficiency. 




Supplementary Figure 9. OLED device lifetime curves.  
OLED device operating lifetime curves (initial luminance 100 cd/m
2
) at constant current under 





Supplementary Figure 10. Synthesis of compound A. 
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Supplementary Figure 12. Synthesis of compound B. 

































H NMR (300 MHz, CDCl3); (b) 
13
C NMR (75 MHz, CDCl3); (c) 
19







Supplementary Figure 14. Synthesis of compound C. 
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Supplementary Figure 16. NMR spectra for complex 1. 
(a) 
1
H NMR (300 MHz, CDCl3); (b) 
13
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Supplementary Figure 17. NMR spectra for complex 2. 
(a) 
1
H NMR (300 MHz, CDCl3); (b) 
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Synthesis of N-(3'-(tert-butyl)-5-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)acetamide: N-(2-
chloro-4-(trifluoromethyl)phenyl)acetamide (1 eq., 5.05 mmol, 1.20 g), 3-(tert-
butyl)phenylboronic acid (2.0 eq., 10.1 mmol, 1.80 g,) and potassium phosphate trihydrate (2.0 
eq., 10.1 mmol, 2.33 g) were mixed in THF/H2O 20:1 (10 mL) and purged with argon. SPhos Pd 
G2 (1 mol%, 0.051 mmol, 37 mg) was added and the mixture was heated at 80°C for 16 h. 
Reaction was cooled to r.t., Et2O (30 mL) was added and the mixture was filtered through 
Celite
®
. The filtrate was diluted with AcOEt (100 mL), washed with water and brine, and dried 
with MgSO4. The solvent was evaporated and the residue was purified by silica column 
chromatography (PE/AcOEt) to afford the product as an off-white solid (92%, 1.55 g). 
1
H NMR (300 MHz, CDCl3): δ 8.53 (d, J = 8.7 Hz, 1H), 7.61 (pseudo dd, J = 8.7, 2.2 Hz, 1H), 
7.52 – 7.42 (m, 3 x 1H overlapped), 7.40 – 7.37 (m, 1H), 7.37 – 7.32 (bs, NH), 7.19 (pseudo dt, J 
= 6.6, 1.9 Hz, 1H), 2.05 (s, 3H, Ac), 1.37 (s, 9H, tBu). 
13
C NMR (75 MHz, CDCl3) δ 168.4 (s, 
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C=O), 152.7 (s, C–tBu), 138.0 (s, Cq), 136.4 (s, Cq), 132.2 (s, Cq)), 129.5 (s, CH), 127.1 (q, J = 
3.6 Hz, CH–C–CF3), 126.4 (s, CH), 126.3 (s, CH), 125.8 (s, CH), 125.5 (q, J = 3.7 Hz, CH–C–
CF3), 124.2 (q, J = 271.8 Hz, CF3), 120.8 (s, CH), 35.1 (s, C(CH3)3), 31.5 (s, C(CH3)3), 25.0 (s, 
CH3 Ac), (Cipso–CF3 was not observed due to overlap with aromatic signals). 
19
F NMR (282 
MHz, CDCl3) δ -62.1 ppm. Anal. Calcd. for C19H20F3NO 335.37): C, 68.05; H, 6.01; N, 4.18. 
Found: C, 68.17; H, 6.18; N, 4.31. See Supplementary Figs. 10 and 11. 
 
Synthesis of 6-(tert-butyl)-3-(trifluoromethyl)-9-acetylcarbazole: In an oven-dried Schlenk 
tube, under argon, N-(3'-(tert-butyl)-5-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)acetamide (1 eq., 
4.47 mmol, 1.50 g), Cu(OAc)2 (20 mol%, 0.89 mmol, 162 mg), Pd(OAc)2 (2 mol%, 0.089 mmol, 
20 mg) and 3 Å molecular sieves were mixed in toluene (20 mL). The flask was purged by 
oxygen and heated at 120°C. The Pd(OAc)2 was added every 8 h (4 × 20 mg). The reaction was 
monitored by 
19
F NMR indicating full completion after 48 h. The mixture was cooled to r.t., 
diluted with AcOEt (60 mL) and filtered through Celite
®
. The filtrate was diluted with AcOEt 
(100 mL) washed with water and brine and dried with MgSO4. The solvent was evaporated and 
the residue was purified by silica column chromatography (PE/AcOEt) to afford the product as 
an off-white solid (68%, 1.01 g). 
1
H NMR (300 MHz, CDCl3): δ 8.46 (d, J = 8.8 Hz, 1H, CH
1
), 8.27 (pseudo s, 1H, CH
4
), 8.04 (d, 
J = 2.1 Hz, 1H, CH
5
), 8.01 (d, J = 8.9 Hz, 1H, CH
8
), 7.71 (pseudo dd, J = 8.8, 1.9 Hz, 1H, CH
2
), 
7.60 (dd, J = 8.9, 2.1 Hz, 1H, CH
7
), 2.90 (s, 3H, Ac), 1.45 (s, 9H, tBu). 
13
C NMR (75 MHz, 
CDCl3) δ 170.1 (s, C=O), 147.5 (C–tBu), 140.9 (s, Cq), 137.1 (s, Cq), 126.8 (s, Cq), 126.1 (s, 
CH
7
), 126.0 (q, J = 32.6 Hz, C–CF3), 125.6 (s, Cq), 124.7 (q, J = 271.7 Hz, CF3), 124.2 (q, J = 
3.6 Hz, CH
2
), 117.0 (s, CH
1
 overlapped with CH
4
), 116.9 (q, J = 3.9 Hz, CH
4
 overlapped with 
CH
1
), 116.8 (s, CH
5
), 115.6 (s, CH
8
), 34.9 (s, C(CH3)3, 31.8 (C(CH3)3, 27.8 (s, CH3 Ac). 
19
F 
NMR (282 MHz, CDCl3) δ -61.2. Anal. Calcd. for C19H18F3NO (333.35): C, 68.46; H, 5.44; N, 
4.20. Found: C, 68.13; H, 5.68; N, 3.97. See Supplementary Figs. 12 and 13. 
 
Synthesis of 6-(tert-butyl)-3-(trifluoromethyl)-9H-carbazole. DBU (2 eq., 6.06 mmol, 904 
µL) was added to 6-(tert-butyl)-3-(trifluoromethyl)-9-acetylcarbazole (1 eq., 3.03 mmol, 1.01 g) 
in MeOH (30 mL), and the mixture was refluxed for 6 h. The reaction was cooled to r.t. and 
volatiles were evaporated. AcOEt (120 mL) was added, washed with water and brine, and dried 
19 
 
over MgSO4. The residue was purified by silica column chromatography (PE/AcOEt) to afford 
the product as a white solid (91%, 800 mg). 
1
H NMR (300 MHz, CDCl3): δ 8.37 (s, 1H, CH
4
), 8.16 (bs, 1H, NH), 8.12 (pseudo s, 1H, CH
5
), 
7.64 (pseudo dd, J = 8.5, 1.7 Hz, 1H, CH
2
), 7.56 (dd, J = 8.6, 1.9 Hz, 1H, CH
8
), 7.47 (d, J = 8.5 
Hz, 1H, CH
1
), 7.41 (d, J = 8.6 Hz, 1H, CH
7
), 1.45 (s, 9H, tBu). 
13
C NMR (75 MHz, CDCl3) δ 
143.6 (s, C–tBu), 141.5 (s, Cq), 138.2 (s, Cq), 125.5 (q, J = 271.2 Hz, CF3), 125.0 (s, CH
7
), 123.4 
(s, Cq), 122.8 (s, Cq), 122.5 (q, J = 3.7 Hz, CH
2
), 121.7 (q, J = 32.1 Hz, C–CF3), 117.9 (q, J = 4.1 
Hz, CH
4
), 116.8 (s, CH
5
), 110.7 (s, CH
1
), 110.6 (s, CH
8
), 34.9 (s, C(CH3)3), 32.1 (s, C(CH3)3). 
19
F NMR (282 MHz, CDCl3) δ -60.1. Anal. Calcd. for C17H16F3N (291.32): C, 70.09; H, 5.54; N, 
4.81. Found: C, 69.82; H, 5.72; N, 4.63. See Supplementary Figs. 14 and 15. 
 
X-Ray Crystallography.  
Crystals of 1 and 2 suitable for X-ray diffraction study were obtained by layering a toluene 
solution with hexanes. Complex 1 and 2 crystallizes with two independent molecules in the unit 
cell and molecules of toluene. The CF3-group was disordered over two half-populated positions 
for the complex 1 (independent molecule A). For the final refinement, the contribution of 
severely disordered toluene molecules in the crystals of 1 was removed from the diffraction data 
with PLATON/SQUEEZE.
1,2 Crystals were mounted in oil on glass fiber and fixed on the 
diffractometer in a cold nitrogen stream. Data were collected using an Oxford Diffraction 
Xcalibur-3/Sapphire3-CCD diffractometer with graphite monochromated Mo Kα radiation (λ = 
0.71073 Å) at 140 K. Data were processed using the CrystAlisPro-CCD and –RED software.
3
 
The structure was solved by direct methods and refined by the full-matrix least-squares against 
F
2
 in an anisotropic (for non-hydrogen atoms) approximation. All hydrogen atom positions were 
refined in isotropic approximation in a “riding” model with the Uiso(H) parameters equal to 1.2 
Ueq(Ci), for methyl groups equal to 1.5 Ueq(Cii), where U(Ci) and U(Cii) are respectively the 
equivalent thermal parameters of the carbon atoms to which the corresponding H atoms are 
bonded. All calculations were performed using the SHELXTL software.
4
  
The principal crystallographic data and refinement parameters: 
Complex 1, CCDC number 1916996, C51H62AuF3N2, Monoclinic, space group P21/n, a = 
23.0603(9) Å, b = 15.7169(5) Å, c = 26.0909(9) Å,  = 103.114(4)°, V = 9209.7(6) Å
3
, Z = 8, 
dcalc = 1.380 g cm
−3
,  = 3.242 mm−1, colorless/block, crystal size 0.25 × 0.21 × 0.09 mm, F(000) 
20 
 
= 3904, Tmin/Tmax 0.73420/1.00000, R1 = 0.0341 (from 18085 unique reflections with I>2σ(I); 
Rint = 0.0449, Rsigma = 0.0392) and wR2 = 0.0852 (from all 73935 unique reflections), GOF = 
1.096, Δρmin/Δρmax = 1.65/–1.28.  
Complex 2, CCDC number 1916995, C41H45AuF6N2, Triclinic, space group P-1, a = 13.2995(6) 
Å, b = 14.8662(6) Å, c = 26.4244(10) Å, α = 74.133(4)°,  = 77.531(3)°, γ = 71.883(4)°,  V = 
4727.0(4) Å
3
, Z = 4, dcalc = 1.232 g cm
−3
,  = 3.160 mm−1, colorless/block, crystal size 0.16 × 
0.11 × 0.07 mm, F(000) = 1752, Tmin/Tmax 0.70618/1.00000, R1 = 0.0396 (from 18562 unique 
reflections with I>2σ(I); Rint = 0.0548, Rsigma = 0.0852) and wR2 = 0.0754 (from all 41002 unique 
reflections), GOF = 1.022, Δρmin/Δρmax = 1.15/–1.28.  
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